SCHEMBL6896518

SCHEMBL6896518

N[C@@H](CS)C(=O)OC(=O)c1ccccc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.50
LMNA P02545 2/20 0.46
TSHR P16473 2/20 0.46
HPGD P15428 5/20 0.44
HSD17B10 Q99714 4/20 0.44
ALOX15 P16050 1/20 0.44
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 4/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KMT2A Q03164 2/20 0.41
HTT P42858 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27850898 0.82 TDP1 (0.56) TDP1LMNATSHRHPGDHSD17B10
SCHEMBL7613313 0.81 TDP1 (0.49) TDP1LMNATSHRHPGDHSD17B10
SCHEMBL28013153 0.81 TDP1 (0.55) TDP1LMNATSHRHPGDHSD17B10
SCHEMBL4410808 0.80 TDP1 (0.50) TDP1LMNATSHRHPGDHSD17B10
SCHEMBL1650196 0.80 TDP1 (0.49) TDP1LMNATSHRHPGDHSD17B10
SCHEMBL7790573 0.80 LMNA (0.60) TDP1LMNATSHRHSD17B10ALDH1A1
SCHEMBL19614688 0.80 TDP1 (0.49) TDP1LMNATSHRHPGDHSD17B10
SCHEMBL6514022 0.79 ALDH1A1 (0.47) TDP1LMNATSHRALDH1A1KDM4E
SCHEMBL28611197 0.79 LMNA (0.55) TDP1LMNATSHRHPGDHSD17B10
SCHEMBL10045875 0.79 TDP1 (0.44) TDP1LMNATSHRHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1747731-A Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders ALTANA PHARMA AG (DE) 2006-03-15 CN claimed
EP-1429807-A2 COMBINATION OF A NSAID AND A PDE-4 INHIBITOR ALTANA Pharma AG (DE) 2004-06-23 EP claimed
WO-2003024489-A2 COMBINATION OF A NSAID AND A PDE-4 INHIBITOR ALTANA PHARMA AG (DE) 2003-03-27 WO claimed
EP-0936899-A4 COSMETIC COMPOSITIONS PROCTER & GAMBLE (US) 2002-01-02 EP claimed
US-6267978-B1 COSMETIC FOR REGULATION OF THE OILY AND/OR SHINY APPEARANCE OF SKIN THE PROCTER & GAMBLE COMPANY 2001-07-31 US claimed
US-6143310-A WATER IN OIL EMULSION CONTAINING AMINO ACID SALT OF SALICYLIC ACID THE PROCTER & GAMBLE COMPANY (US) 2000-11-07 US claimed
EP-0936899-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-08-25 EP claimed
CN-1226820-A Cosmetic composition PROCTER & GAMBLE (US) 1999-08-25 CN claimed
WO-1998010741-A1 COSMETIC COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-03-19 WO claimed